Moneycontrol PRO
UPCOMING EVENT:Know how Global Investing can be spread beyond the US markets by joining an engaging webinar on November 30, 11:30 a.m.
you are here: HomeNewsIndia

COVID-19 Vaccine Tracker: Over 64.75 lakh jabs given on October 25

Biological E Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, said Mahima Datla, Managing Director, BE

October 26, 2021 / 09:50 AM IST
On the 283rd day of the nationwide COVID-19 vaccination drive, 26.04 lakh people received their first shot and 38.7 lakh their second dose. (Representative image: Reuters)

On the 283rd day of the nationwide COVID-19 vaccination drive, 26.04 lakh people received their first shot and 38.7 lakh their second dose. (Representative image: Reuters)

India administered more than 64.75 lakh COVID-19 vaccine doses in the last 24 hours, taking the vaccination count to over 102.9 crore, according to the Union Health Ministry update on October 26.

On the 283rd day of the nationwide vaccination drive, 26.04 lakh people received their first shot and 38.7 lakh their second dose.

The vaccination drive has picked pace over the last few weeks. It took the country 85 days to give the first 10 crore doses, the next 10 crore took 45 days and, in another 29 days, India touched the 30-crore mark.

By the next 24 days, the count reached 40 crore and in the following 20 days, it crossed the 50-crore mark on August 6. By September 13, 75 crore vaccines had been given. The biggest jump, however, came on September 17, when more than 2.1 crore doses were given in a day.

On October 21, India scripted history with the cumulative COVID-19 vaccine doses administered in the country surpassing the 100-crore milestone.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The government has revised the gap between the two doses for the Oxford-AstraZeneca's Covishield, manufactured by the Serum Institute of India (SII), to 12-16 weeks. However, the interval for the second dose of Bharat Biotech's Covaxin remains unchanged at four weeks.

Prime Minister Narendra Modi launched the nationwide vaccination drive on January 16, with healthcare workers at the frontline of India's COVID-19 battle getting their first jabs. The next phase started on March 1 for people over 60 years and those aged 45 and above with specified comorbid conditions. From April 1, the drive was expanded to include all aged 45 and above.

The government then decided to expand the vaccination drive by allowing everyone above 18 to be vaccinated from May 1.

Here are some major developments related to vaccination:

- The Centre called on all panchayat leaders on October 25 to play an active role in COVID-19 vaccination for children once it is approved, while expressing hope that it will pave the way for the reopening of schools. The vaccination for those below 18 years of age is yet to be started in the country, which has already crossed the 100-crore-dose mark in vaccinating adults against COVID-19.

- Biological E Limited (BE) is expecting its COVID-19 vaccine Corbevax to be rolled out by the end of November even as the city-based firm is getting ready with 100 million doses for the launch, Mahima Datla, Managing Director, BE said on the day. Speaking to reporters on the sidelines of signing a financing agreement with US International Development Finance Corporation (DFC), she said currently the manufactured doses are being sent to Central Drugs Laboratory (CDL), Kasauli in Himachal Pradesh for regulatory testing.

- India is committed to supplying COVID-19 vaccines to other nations and such supplies are likely to begin by the end of this year, as the abundant production will not just meet domestic needs but also generate surplus for exports, a top government official said on the day. The official, however, added that the supply of vaccines to other nations will have to be balanced against the country's vaccination program.

- The BJP-led EDMC House passed a resolution on the day thanking PM Modi, doctors and scientists for helping India achieve the milestone of administering over 100 crore COVID-19 vaccine doses in the country's fight against the pandemic. The House termed the milestone an "unforgettable achievement" and said that "history has been scripted".

- More than 107.22 crore COVID-19 vaccine doses have been provided to states and union territories so far, the Union Health Ministry said on the day. More than 12.75 crore balance and unutilised vaccine doses still available with states and UTs, it said.

- The Tamil Nadu government has advised the administration in all the districts to step up the COVID-19 vaccination programme as the percentage-wise vaccination for the second dose, in comparison to the state's population, is below the national average, according to a top official.

Here is the vaccination count for states/UTs
StatesTotal Beneficiaries
Andhra Pradesh5,07,88,151
Arunachal Pradesh12,84,923
Assam 2,73,05,326
Bihar 6,50,12,666
Chandigarh14,51,998
Chhattisgarh2,14,15,974
Delhi2,01,28,564
Goa21,26,640
Gujarat6,90,02,235
Haryana 2,54,63,063
Himachal Pradesh 89,47,304
Jammu and Kashmir 1,42,79,512
Jharkhand1,99,49,609
Karnataka6,36,42,985
Kerala3,82,23,885
Madhya Pradesh6,89,62,536
Maharashtra9,58,08,623
Odisha 3,59,26,212
Punjab2,18,32,891
Rajasthan6,16,58,477
Tamil Nadu 5,67,86,842
Telangana3,05,12,333
Uttar Pradesh12,67,38,081
Uttarakhand1,11,38,326
West Bengal7,30,95,396
(With inputs from PTI)
Moneycontrol News
first published: Oct 26, 2021 09:50 am

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark